# A Prospective Multi-center Phase III Randomized Controlled Trial

> **NCT02607592** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 293 (estimated)

## Conditions studied

- Carcinoma，Non-Small-Cell Lung

## Interventions

- **DRUG:** cisplatin and pemetrexed
- **DRUG:** nedaplatin+pemetrexed

## Key facts

- **NCT ID:** NCT02607592
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2022-06
- **Final completion:** 2022-12
- **Target enrollment:** 293 (ESTIMATED)
- **Last updated:** 2022-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02607592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02607592, "A Prospective Multi-center Phase III Randomized Controlled Trial". Retrieved via AI Analytics 2026-09-16 from https://api.ai-analytics.org/clinical/NCT02607592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*